What is Hemlibra 105mg/0.7ml, injection solution used for?

( ARTG ) Hemlibra is indicated for routine prophylaxis to prevent bleeding or reduce the frequency of bleeding episodes in adult and paediatric patients with haemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors.

What are the side effects of Hemlibra 105mg/0.7ml, injection solution?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Hemlibra 105mg/0.7ml, injection solution be used during pregnancy?

( AHT ) For the active ingredient emicizumab You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Hemlibra 105mg/0.7ml, injection solution belong to?

Hemlibra 105mg/0.7ml, injection solution: ATC B02BX06. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Hemlibra 105mg/0.7ml, injection solution

INN: X

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Roche Pharma (Schweiz) AG

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.